HYPR
Hyperfine Inc
NASDAQ: HYPR · HEALTHCARE · MEDICAL DEVICES
$1.87
+12.65% today
Updated 2026-05-01
Market cap
$163.54M
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Hyperfine Inc (HYPR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.37M | $-21.52M | $-47.18M | $-72.34M | $-41.81M | $-38.77M | $-27.95M |
| Capital expenditures | $244000.00 | $1.57M | $2.71M | $585000.00 | $804000.00 | $383000.00 | $1.19M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $896000.00 | $1.12M | $6.90M | $10.65M | $4.74M | $4.36M | $2.80M |
| Free cash flow | $-18.62M | $-23.09M | $-49.89M | $-72.92M | $-42.61M | $-39.15M | $-29.13M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $126.87M | $-72.92M | — | — | — |